| Return of genomic results to research participants: the floor, the ceiling, and the choices in between GP Jarvik, LM Amendola, JS Berg, K Brothers, EW Clayton, W Chung, ... The American Journal of Human Genetics 94 (6), 818-826, 2014 | 439 | 2014 |
| Identifying Sources of Groundwater Pollution: An Optimization Approach SM Gorelick, B Evans, I Remson Water Resources Research 19 (3), 779-790, 1983 | 387 | 1983 |
| The law of genetic privacy: applications, implications, and limitations EW Clayton, BJ Evans, JW Hazel, MA Rothstein Journal of Law and the Biosciences 6 (1), 1-36, 2019 | 291 | 2019 |
| Much ado about data ownership BJ Evans Harv. JL & Tech. 25, 69, 2011 | 183 | 2011 |
| Clinical sequencing exploratory research consortium: accelerating evidence-based practice of genomic medicine RC Green, KAB Goddard, GP Jarvik, LM Amendola, PS Appelbaum, ... The American Journal of Human Genetics 98 (6), 1051-1066, 2016 | 175 | 2016 |
| Return of results: ethical and legal distinctions between research and clinical care W Burke, BJ Evans, GP Jarvik American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2014 | 126 | 2014 |
| Seven pillars of a new evidentiary paradigm: the Food, Drug, and Cosmetic Act enters the genomic era BJ Evans Notre Dame L. Rev. 85, 419, 2009 | 101 | 2009 |
| The FDA and genomic tests—getting regulation right BJ Evans, W Burke, GP Jarvik New England Journal of Medicine 372 (23), 2258-2264, 2015 | 98 | 2015 |
| Barbarians at the gate: consumer-driven health data commons and the transformation of citizen science BJ Evans American journal of law & medicine 42 (4), 651-685, 2016 | 97 | 2016 |
| A policy framework for public health uses of electronic health data D McGraw, K Rosati, B Evans Pharmacoepidemiology and drug safety 21, 18-22, 2012 | 93 | 2012 |
| Advancing artificial intelligence in health settings outside the hospital and clinic N Aggarwal, M Ahmed, S Basu, JJ Curtin, BJ Evans, ME Matheny, ... NAM perspectives 2020, 2020 | 61 | 2020 |
| To do no harm—and the most good—with AI in health care CB Goldberg, L Adams, D Blumenthal, PF Brennan, N Brown, AJ Butte, ... Nejm Ai 1 (3), AIp2400036, 2024 | 60 | 2024 |
| Meeting the moment: addressing barriers and facilitating clinical adoption of artificial intelligence in medical diagnosis J Adler-Milstein, N Aggarwal, M Ahmed, J Castner, BJ Evans, ... NAM perspectives 2022, 2022 | 53 | 2022 |
| Creating a data resource: what will it take to build a medical information commons? PA Deverka, MA Majumder, AG Villanueva, M Anderson, AC Bakker, ... Genome Medicine 9, 1-5, 2017 | 53 | 2017 |
| Regulating direct-to-consumer personal genome testing AL McGuire, BJ Evans, T Caulfield, W Burke Science 330 (6001), 181-182, 2010 | 50 | 2010 |
| The Challenge of Regulating Clinical Decision Support Software After 21st Century Cures B Evans, P Ossorio American journal of law & medicine 44 (2-3), 237-251, 2018 | 48 | 2018 |
| Encouraging translational research through harmonization of FDA and common rule informed consent requirements for research with banked specimens BJ Evans, EM Meslin The Journal of Legal Medicine 27 (2), 119-166, 2006 | 48 | 2006 |
| Who owns the data in a medical information commons? AL McGuire, J Roberts, S Aas, BJ Evans The Journal of Law, Medicine & Ethics 47 (1), 62-69, 2019 | 46 | 2019 |
| What will it take to reap the clinical benefits of pharmacogenomics? BJ Evans Food and Drug Law Journal 61 (4), 753-794, 2006 | 46 | 2006 |
| Unregulated health research using mobile devices: Ethical considerations and policy recommendations MA Rothstein, JT Wilbanks, LM Beskow, KM Brelsford, KB Brothers, ... Journal of Law, Medicine & Ethics 48 (S1), 196-226, 2020 | 43 | 2020 |
